featured
Efficacy of Anti-CD3 Monoclonal Antibodies in Delaying the Progression of Recent-Onset Type 1 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of anti-CD3 monoclonal antibodies in delaying the progression of recent-onset type 1 diabetes mellitus: A systematic review, meta-analyses and meta-regression
Diabetes Obes Metab 2023 Aug 14;[EPub Ahead of Print], MT Ashraf, SH Ahmed Rizvi, MAB Kashif, MK Shakeel Khan, SH Ahmed, MS AsgharFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.